NRG LU005/ Chemo-radiation versus Chemo-radiation plus Atezolizumab/ Yuhchyau Chen
Basic Study Information
Purpose:Location: University of Rochester
This phase II/III trial studies how well chemotherapy and radiation therapy (chemoradiation)
with or without atezolizumab works in treating patients with limited stage small cell
lung cancer. Drugs used in chemotherapy, such as etoposide, cisplatin, and carboplatin,
work in different ways to stop the growth of tumor cells, either by killing the cells,
by stopping them from dividing, or by stopping them from spreading. Radiation therapy
uses high energy x-rays to kill tumor cells and shrink tumors. Immunotherapy with
monoclonal antibodies, such as atezolizumab, may help the body's immune system attack
the cancer, and may interfere with the ability of tumor cells to grow and spread.
Giving chemoradiation with or without atezolizumab may work better in treating patients
with limited stage small cell lung cancer.
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search